OsteoporosisWRAP—
Evidence-Based and
Practical Approaches to
Bisphosphonate Therapy:

The Road to Optimal Outcomes

WebCAST CME Disclosure

Please read this notice and click the acknowledgement
at the bottom of the page to continue.

Release Date:

May 10, 2009

Expiration Date:

May 10, 2011

Intended Audience:

This program is designed for all practitioners with the following specialties or subspecialties: Primary care physicians, family medicine specialists: bone metabolism experts, preventive medicine specialists, gynecologists, nurse practitioners, orthopedic surgeons, consulting pharmacists, internal medicine specialists, endocrinologists, women's health physicians, geriatric nurse practitioners, and rheumatologists.

Registration:

Enrollment for this HealthWRAP is complimentary, and clinicians are invited to participate in this CME-certified HealthWRAPs and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.

Grantor Support:

The following program has been supported by
an independent medical educational grant from
Roche Pharmaceuticals.

Accreditation Statement for Jointly-Sponsored Programs:

This activity has been planned and implemented in accordance with the Essentials Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Massachusetts Medical School and CMEducation Resources, LLC. The University of Massachusetts Medical School is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

The University of Massachusetts Medical School designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure:

It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Policy on Faculty Disclosure:

It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Program Faculty:

Sol Epstein, M.D.
Clinical Professor of Medicine and Geriatrics
Mount Sinai School of Medicine
New York, New York

Faculty Disclosures:

Dr. Epstein discloses that he has been a consultant for Roche, GlaxoSmithKline, Merck and Amgen. He has received honoraria for speaking from Roche/GlaxoSmthKlin and Merck

Educational Objectives:

Physicians, pharmacists, and other healthcare providers will:

• Learn how recent advances in basic and clinical research have helped to advance strategies for bisphosphonate therapy for osteoporosis management
• Learn how to evaluate recent clinical trials in bisphosphonate therapy and basic research and how to apply the results of these trials to optimize management of patients with postmenopausal osteoporosis.
• Learn to analyze concepts, strategies, and findings emanating from basic research studies in the pharmacokinetics and pharmacodynamics of agents used to treat osteoporosis and determine directions for future research and trial design, and implications for clinical practice.
• Learn to analyze concepts, strategies, and findings emanating from clinical research studies in osteoporosis—at the level of BMD, regimen adherence and persistence, dose and dosing frequency—and determine possible implications for clinical practice.
• Learn evidence-based approaches to reducing progression of osteoporosis, and reducing risk of fracture complications based on finding reported in the latest clinical research.
• Learn how, based on research and evidence, to select safe and effective pharmacotherapy for prevention and treatment of postmenopausal osteoporosis.
• Learn how landmark trials and analyses focusing on BMD, bisphosphonate therapy, predictive risk, and fracture reduction should guide clinical management of patients with osteoporosis.
  

Disclaimer:

Copyright © 2011 Resources, LLC All rights reserved.

Reproduction, distribution, or translation without express written permission is strictly prohibited.

Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.

Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.

Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman.

Opinions expressed herein are not necessarily those of CMEducation Resources, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

Copyright © 2011 Resources, LLC All rights reserved.